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ABSTRACT 
Objective: Although brucellosis has almost been eradicated from most of the developed countries, it still continues to be a major but somehow 
neglected disease in the developing and underdeveloped countries. In the past, hematological abnormalities like anemia, thrombocytopenia have 
been reported to be seen in brucellosis patients. The objective of the present study is to observe and study the coagulation profile of patients 
suffering from acute brucellosis.  
Methods: Blood samples were collected from brucellosis patients and healthy volunteers and were analyzed in automated blood coagulation 
analyzer and automated hematology analyzer to find out the values of prothrombin time (PT), activated partial thromboplastin time (aPTT) and 
platelet count.  
Results: Statistical analysis revealed that there was marginal increase in the aPTT level and platelet count in brucellosis patients than that of the 
control patients.  
Conclusion: The study revealed that there might be a tendency of prolonged aPTT and increase in platelet levels in brucellosis patients.  
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INTRODUCTION 
Brucellosis is a zoonosis caused by the gram negative Brucella 
species (Corbel, 1997). Many species of Brucella have been 
discovered till date but four of them are noticed to be most 
pathogenic to humans. These are B. melitensis, B. abortus, B. suis and 
B. canis. Dogs and pigs host B. canis and B. suis respectively while B. 
melitensis and B. abortus are found mainly in sheep, goats, camels 
and cattle (El-Koumi et al, 2013).Generally B. melitensis and B. suis 
affect humans more than B. abortus and B. canis but any species of 
Brucella can cause serious problems (Corbel, 2006). 
Common pathways of transmission of this disease are: consumption 
of unpasteurized milk and other dairy products like cheese, coming 
in contact with infected animals, inhaling infected aerosols, through 
conjunctiva or through cuts on skin. Transmission through sexual 
contact or from mother to progeny is rare but possible ("Diagnosis 
and Management of Acute Brucellosis in Primary Care". Brucella 
Subgroup of the Northern Ireland Regional Zoonoses Group. August 
2004).. 
Brucellosis is found to be acute in majority of the cases. The patients 
mostly suffer from undulant fever, joint and muscle pain, headache, 
sweats fatigue and weight loss (Atluri et al, 2011). 
This highly contagious disease has been eradicated from countries 
like Ireland (."Ireland free of brucellosis". RTÉ. 2009-07-01), Malta 
(Rizzo Naudi, 2005). In New Zealand, Brucellosis is limited to sheep 
only (."MAF Biosecurity New Zealand: Brucellosis". Ministry of 
Agriculture and Forestry of New Zealand ) and in Australia; cattle 
Brucellosis is eradicated; but pigs are affected by this disease 
("Queensland Health: Brucellosis”, State of Queensland,Queensland 
Health, 2010-11-24; Lehane, 1996). But in Middle East, Africa, South 
East and central Asia, South America and some Mediterranean 
countries, this disease still prevails infecting animals and as well as 
human.   
Coagulation profile is a screening test that is generally done to 
identify the reason behind abnormal bleeding of a patient; it may 
also be requested before a procedure which might cause bleeding 
such as surgery to confirm that the patient has no problem in blood 
clotting. A coagulation profile mainly includes Prothrombin time 
(PT), Activated Partial Thromboplastin Time (aPTT), Fibrinogen 
Degradation Product (FDP), and Platelet count (Fischbach and 
Dunning, 2008). 
Previously, patients suffering from Brucellosis are reported to have 
hematological abnormalities like disseminated intravascular 
coagulation (DIC), anemia, pancytopenia, leukopenia and 
thrombocytopenia (Akdeniz et al, 1998). As there is no study on 
Indian population regarding this, we present here coagulation 
profile of Brucellosis patients and normal, healthy persons to do a 
comparative study in the levels of PT, APTT and Platelet count.  
MATERIALS AND METHODS 
Subjects  
For the study of coagulation profile, three persons volunteered who 
were apparently healthy, not taking any medicine and did not have 
any history of liver disease or any serious disease in the past. They 
were considered as control of the experiment. Three patients 
suffering from acute brucellosis were chosen for the comparative 
study of their coagulation profile. The details of the patients and the 
volunteers are listed in Table.1.   
Selection of patients  
The brucellosis patients were selected after performing the 
following clinical tests, thus confirming the presence of antibodies 
(Table1) against brucella (a minimum titer of 1:160 was taken 
reactive for SAT test).   
Serum Agglutination Test (SAT)  
IgG ELISA 
IgM ELISA  
Collection of sample 
For the test of prothrombin time (PT) and activated partial 
Thromboplastin time (aPTT) in an automated blood coagulation 
analyzer, small amount of blood was drawn from the patients as well 
as the volunteers in test tubes containing the anticoagulant sodium 
citrate.  
To find out the platelet count in an automated hematology analyzer, 
blood was collected in a small test tubes containing EDTA. 
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Coagulation profile analysis 
For the study of coagulation profile, prothrombin Time (PT), 
activated partial thromboplastin time (aPTT) and platelet count of 
the six test subjects were measured in laboratory.  
The samples were centrifuged to differentiate the plasma from the 
blood cells and analysis of the plasma was done in the automated 
blood coagulation analyzer Sysmex CA-500. The tests were repeated 
twice and the mean values were taken. 
The tests for activated partial thromboplastin time (APTT) were 
done in a similar procedure using the same instrument as mentioned 
above. 
The platelet count was done in the automated hematology analyzer – 
Sysmex XT-4000i; (Siemens, Deerfield, IL, USA.). Tests were 
repeated twice and the mean values were taken. 
Statistical analysis 
The data was statistically analyzed by performing t-Test assuming 
equal variances and the difference was considered significant when * 
P<0.1. All the values were expressed as mean ± standard deviation 
(SD) ± standard error mean (SEM). 
RESULT 
Apparently there was no significant change in prothrombin time 
(PT) of the six subjects (Table 2).  The aPTT values and platelet 
count were marginally increased for the patients suffering from 
acute brucellosis than those of the healthy volunteers (Table.2.).  
DISCUSSION 
Patients with acute brucellosis are previously reported to have 
hematological abnormalities like thrombocytopenia, anemia, 
pancytopenia, leukopenia, and disseminated intravascular 
coagulation (Akdeniz et al, 1998).    
The activated partial thromboplastin time is basically a performance 
indicator of the coagulation factors involved in the intrinsic and 
common pathway of coagulation cascade. There was marginal 
increase in the aPTT level of the patients suffering from acute 
brucellosis (Table 2). Apparently, it may be due to the increased 
level of immunoglobulin in brucellosis patients. The markedly 
increased immunoglobulins in brucellosis might have acted as 
partial antibody response against factor VIII of intrinsic pathway 
thus resulting in prolonged aPTT level.  
In any chronic inflammation, the platelet count is increased. 
Brucellosis also causes chronic inflammation (Fretin, 2008). The 
increase in platelet count may also be due to dysproteinemia which 
occurs in brucellosis. 
CONCLUSION 
It may be concluded from the above study that there might be a 
tendency of increased platelet count and prolonged aPTT levels in 
patients suffering from acute brucellosis. 
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Table.1: Shows details (name, age, sex, religion, SAT test) of the 
test subjects. 
 
NAME AGE SEX RELIGION SAT TEST 
P.G 24 Male Hinduism Positive (1:640) 
S.A 32 Male Hinduism Positive (1:160) 
B.M 50 Female Hinduism Positive (1:160) 
L.S 38 Female Hinduism      Negative 
R.N 42 Female Hinduism      Negative 
S.G 60 Male Hinduism      Negative 
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 CONTROL 
(mean ± SD ± SEM) 
TEST 





PT (sec) 12.03±0.81 ±0.47 11.93 ± 1.55 ± 0.9  0.099 Not significant 
aPTT (sec) 22.1 ± 1.91 ± 1.106 27.07 ± 4.0 ± 2.31  -1.939 Significant at 0.10 level 
Platelets (/mm3) 175000 ± 25000 ± 14433.76 250333.3 ± 82403.48 -1.515 Significant at 0.10 level 
